Why have the complications of diabetes mellitus declined over the past 30 years?

Journal of the American Medical Directors Association

Volumn 15, Issue 7, 2014, Pages 449-453

  Morley, John E ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT; INSULIN; METFORMIN; ANTIDIABETIC AGENT;

ACUTE HEART INFARCTION; AMPUTATION; BLOOD PRESSURE; CEREBROVASCULAR ACCIDENT; DEATH; DIABETES MELLITUS; DIET RESTRICTION; EDITORIAL; END STAGE RENAL DISEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; SMOKING; ADOLESCENT; ADULT; AGED; CHILD; DIABETES COMPLICATIONS; INFANT; MIDDLE AGED; OBESITY; PRESCHOOL CHILD; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; MIDDLE AGED; OBESITY; UNITED STATES; YOUNG ADULT;

EID: 84903159558     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2014.04.022     Document Type: Editorial

References (92)

1. Gregg E.W., Li Y., Wang J., et al. Changes in diabetes-related complications in the United States, 1990-2010. NEngl J Med 2014, 370:1514-1523.
2. Anonymous. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997, 20:1183-1197.
3. Anonymous. The fifth report of the Joint National Committee on detection, evaluation, and treatment of high blood pressure (JNC V). Arch Intern Med 1993, 153:154-183.
4. Yoon S.S., Ostchega Y., Louis T. Recent trends in the prevalence of high blood pressure and its treatment and control, 1999-2008. NCHS Data Brief 2010, 48:1-8.
5. Bromfield S.G., Bowling C.B., Tanner R.M., et al. Trends in hypertension prevalence, awareness, treatment, and control among US adults 80 years and older, 1988-2010. JClin Hypertens (Greenwich) 2014, 16:270-276.
6. Koka M., Joseph J., Aronow W.S. Adequacy of control of hypertension in an academic nursing home. JAm Med Dir Assoc 2007, 8:538-540.
7. Morley J.E. Hypertension: Is it overtreated in the elderly?. JAm Med Dir Assoc 2010, 11:147-152.
8. Simonson W., Han L.F., Davidson H.E. Hypertension treatment and outcomes in US nursing homes: Results from the US National Nursing Home Survey. JAm Med Dir Assoc 2011, 12:44-49.
9. Aronow W.S. Treatment of hypertension in the elderly. JAm Med Dir Assoc 2013, 14:847.
10. Welsh T., Gladman J., Gordon A.L. The treatment of hypertension in care home residents: A systematic review of observational studies. JAm Med Dir Assoc 2014, 15:8-16.
11. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001, 285:2486-2497.
12. Axsom K., Berger J.S., Schwartzbard A.Z. Statins and diabetes: The good, the bad, and the unknown. Curr Atheroscler Rep 2013, 15:299.
13. Mann D., Reynolds K., Smith D., Muntner D. Trends in statin use and low-density lipoprotein cholesterol levels among US adults: Impact of the 2001 National Cholesterol Education Program guidelines. Ann Pharmachother 2008, 42:1208-1215.
14. Stone NJ, Robinson J, Lichtenstein AH, et al. 2013 ACC/AHA Guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines [published online ahead of print November 7, 2013]. J Am Coll Cardiol. http://dx.doi.org/10.1016/j.jacc.2013.11.002.
15. Morley J.E., Mahon G. Statins and the nursing home. JAm Med Dir Assoc 2013, 14:853-854.
16. Joseph J., Koka M., Aronow W.S. Prevalence of use of antiplatelet drugs, beta blockers, statins, and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in older patients with coronary artery disease in an academic nursing home. JAm Med Dir Assoc 2008, 9:124-127.
17. Sanford A., Morley J.E. Are the new guidelines for cholesterol and hypertension age friendly?. JAm Med Dir Assoc 2014, 15:373-375.
18. MacIntosh C., Morley J.E., Chapman I.M. The anorexia of aging 2000, 16:983-995.
19. Morley J.E. The cholesterol conundrum. JAm Geriatr Soc 2011, 59:1955-1956.
20. Morley J.E. Undernutrition in older adults. Fam Pract 2012, 29:i89-i93.
21. Silva R.B., Eslick G.D., Duque G. Exercise for falls and fracture prevention in long-term facilities: A systematic review and meta-analysis. JAm Med Dir Assoc 2013, 14:685-689.e2.
22. Lenze E.J., Host H.H., Hildebrand M.W., et al. Enhanced medical rehabilitation increases therapy intensity and engagement and improves functional outcomes in postacute rehabilitation of older adults: A randomized-controlled trial. JAm Med Dir Assoc 2012, 13:708-712.
23. Lam L.C., Chau R.C., Wong B.M., et al. A1-year randomized controlled trial comparing mind body exercise (Tai Chi) with stretching and toning exercise on cognitive function in older Chinese adults at risk of cognitive decline. JAm Med Dir Assoc 2012, 13:568.e15-568.e20.
24. Yamada M., Arai H., Sonoda T., Aoyama T. Community-based exercise program is cost-effective by preventing care and disability in Japanese frail older adults. JAm Med Dir Assoc 2012, 13:507-511.
25. Valenzuela T. Efficacy of progressive resistance training interventions in older adults in nursing homes: A systematic review. JAm Med Dir Assoc 2012, 13:418-428.
26. Singh N.A., Quine S., Clemson L.M., et al. Effects of high-intensity progressive resistance training and targeted multidisciplinary treatment of frailty on mortality and nursing home admissions after hip fracture: A randomized controlled trial. JAm Med Dir Assoc 2012, 13:24-30.
27. Spruit M.A., Polkey M.I., Celli B., et al. Predicting outcomes from 6-minute walk distance in chronic obstructive pulmonary disease. JAm Med Dir Assoc 2012, 13:291-297.
28. Colberg S.R., Zarrabi L., Bennington L., et al. Postprandial walking is better for lowering the glycemic effect of dinner than pre-dinner exercise in type 2 diabetic individuals. JAm Med Dir Assoc 2009, 10:394-397.
29. Rolland Y., Abellan van Kan G., Vellas B. Physical activity and Alzheimer's disease: From prevention to therapeutic perspectives. JAm Med Dir Assoc 2008, 9:390-405.
30. Morley J.E. The magic of exercise. JAm Med Dir Assoc 2008, 9:375-377.
31. Colberg S.R., Grieco C.R., Somma C.T. Exercise effects on postprandial glycemia, mood, and sympathovagal balance in type 2 diabetes. JAm Med Dir Assoc 2014, 15:261-266.
32. Landi F., Onder G., Bernabei R. Sarcopenia and diabetes: Two sides of the same coin. JAm Med Dir Assoc 2013, 14:540-541.
33. Leenders M., Verdijk L.B., van der Hoeven L., et al. Patients with type 2 diabetes show a greater decline in muscle mass, muscle strength, and functional capacity with aging. JAm Med Dir Assoc 2013, 14:585-592.
34. Morley J.E. Diabetes, sarcopenia, and frailty. Clin Geriatr Med 2008, 24:455-469.
35. Barbat-Artigas S., Rolland Y., Vellas B., Aubertin-Leheudre M. Muscle quantity is not synonymous with muscle quality. JAm Med Dir Assoc 2013, 14:852.e1-852.e7.
36. Chen L.K., Liu L.K., Woo J., et al. Sarcopenia in Asia: Consensus report of the Asian Working Group for Sarcopenia. JAm Med Dir Assoc 2014, 15:95-101.
37. Amigues I., Schott A.M., Amine M., et al. Low skeletal muscle mass and risk of functional decline in elderly community-dwelling women: The prospective EPIDOS study. JAm Med Dir Assoc 2013, 14:352-357.
38. Boirie Y. Fighting sarcopenia in older frail subjects: Protein fuel for strength, exercise for mass. JAm Med Dir Assoc 2013, 14:140-143.
39. Roman D., Mahoney K., Mohamadi A. Sarcopenia: What's in a name?. JAm Med Dir Assoc 2013, 14:80-82.
40. Cesari M., Vellas B. Sarcopenia: A novel clinical condition or still a matter for research?. JAm Med Dir Assoc 2012, 13:766-767.
41. Morley J.E., Abbatecola A.M., Argiles J.M., et al. Sarcopenia with limited mobility: An international consensus. JAm Med Dir Assoc 2011, 12:403-409.
42. Fielding R.A., Vellas B., Evans W.J., et al. Sarcopenia: An undiagnosed condition in older adults: Current consensus definition: Prevalence, etiology, and consequences. International Working Group on Sarcopenia. JAm Med Dir Assoc 2011, 12:249-256.
43. Bauer J.M., Kaiser M.J., Sieber C.C. Sarcopenia in nursing home residents. JAm Med Dir Assoc 2008, 9:545-551.
44. Cao L., Chen S., Zou C., et al. Apilot study of the SARC-F scale on screening sarcopenia and physical disability in the Chinese older people. JNutr Health Aging 2014, 18:277-283.
45. Morley J.E., von Haehling S., Anker S.D., Vellas B. From sarcopenia to frailty: A road less traveled. JCachexia Sarcopenia Muscle 2014, 5:5-8.
46. Morley J.E., Malmstrom T.K. Frailty, sarcopenia, and hormones. Endocrinol Metab Clin North Am 2013, 42:391-405.
47. Von Haehling S., Morley J.E., Anker S.D. From muscle wasting to sarcopenia and myopenia: Update 2012. JCachexia Sarcopenia Muscle 2012, 3:213-217.
48. Rolland Y., Lauwers-Cances V., Cristini C., et al. Difficulties with physical function associated with obesity, sarcopenia, and sarcopenic-obesity in community-dwelling elderly women: The EPIDOS (EPIDemiologie de l'OSteoporose) Study. Am J Clin Nutr 2009, 89:1895-1900.
49. Morley J.E. Sarcopenia: Diagnosis and treatment. JNutr Health Aging 2008, 12:452-456.
50. Morley J.E. Androgens and aging. Maturitas 2001, 38:61-71.
51. Wand C., Nieschlag E., Swerdloff R., et al. Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations. JAndrology 2009, 30:1-9.
52. Drey M., Krieger B., Sieber C.C., et al. Motoneuron loss is associated with sarcopenia. JAm Med Dir Assoc 2014, 15:435-439.
53. Morley J.E. Developing novel therapeutic approaches to frailty. Curr Pharm Des 2009, 15:3384-3395.
54. Hampp C., Borders-Hemphill V., Money D.G., Sysowski D.K. Use of antidiabetic drugs in the U.S., 2003-2012. Diabetes Care 2014, 37:1367-1374.
55. Wysowski D.K., Armstrong G., Governale L. Rapid increase in the use of oral antidiabetic drugs in the United States, 1990-2001. Diabetes Care 2003, 26:1852-1855.
56. Anonymous Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS34). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352:854-865.
57. Gosmanova E.O., Canada R.B., Mangold T.A., et al. Effect of metformin-containing antidiabetic regimens on all-cause mortality in veterans with type 2 diabetes mellitus. Am J Med Sci 2008, 336:241-247.
58. Leverve X.M., Guigas B., Detaille D., et al. Mitochondrial metabolism and type-2 diabetes: A specific target of metformin. Diabetes Metab 2003, 29. 6S88-94.
59. Kumar V.B., Bernardo A.E., Vyas K., et al. Effect of metformin on nitric oxide synthase in genetically obese (ob/ob) mice). Life Sci 2001, 69:2789-2799.
60. Vitale C., Mercuro G., Cornoldi A., et al. Metformin improves endothelial function in patients with metabolic syndrome. JIntern Med 2005, 258:250-256.
61. Bouskela E., Cyrino F.Z., Wiernsperger N. Effects of insulin and the combination of insulin plus metformin (Glucophage) on microvascular reactivity in control and diabetic hamsters. Angiology 1997, 48:503-514.
62. Tobias D.K., Pan A., Jackson C.L., et al. Body-mass index and mortality among adults with incident type 2 diabetes. NEngl J Med 2014, 370:233-244.
63. Kalantar-Zadeh K., Horwich T.B., Oreopoulos A., et al. Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care 2007, 10:433-442.
64. Wedick N.M., Barrett-Connor E., Knoke J.D., Wingard D.L. The relationship between weight loss and all-cause mortality in older men and women with and without diabetes mellitus: The Rancho Bernardo study. JAm Geriatr Soc 2002, 50:1810-1815.
65. Morley J.E. Weight loss in older persons: New therapeutic approaches. Curr Pharm Des 2007, 13:3637-3647.
66. st century: Applying these principles to long-term diabetes care. JAm Med Dir Assoc 2013, 14:777-780.
67. Benetos A., Novella J.L., Guerci B., et al. Pragmatic diabetes management in nursing homes: Individual care plan. JAm Med Dir Assoc 2013, 14:791-800.
68. Lee J.S., Auyeung T.W., Chau P.P., et al. Obesity can benefit survival-a 9-year prospective study in 1614 Chinese nursing home residents. JAm Med Dir Assoc 2014, 15:342-348.
69. Wu H.Y., Huang J.W., Lin H.J., et al. Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: Systematic review and Bayesian network meta-analysis. BMJ 2013, 347:f6008.
70. Margolis K.L., O'Connor P.J., Morgan T.M., et al. Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: The ACCORD randomized trial. Diabetes Care 2014, 37:1721-1728.
71. Dluhy R.G., McMahon G.T. Intensive glycemic control in the ACCORD and ADVANCE trials. NEngl J Med 2008, 358:2630-2633.
72. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. NEngl J Med 2009, 360:129-139.
73. Morley J.E. Frailty, falls, and fractures. JAm Med Dir Assoc 2013, 14:149-151.
74. Morley J.E., Rolland Y., Tolson D., Vellas B. Increasing awareness of the factors producing falls: The mini falls assessment. JAm Med Dir Assoc 2012, 13:87-90.
75. Morley J.E. Falls and fractures. JAm Med Dir Assoc 2007, 8:276-278.
76. Sinclair A., Morley J. Frailty and diabetes. Lancet 2013, 382:1386-1387.
77. Kirkman S., Briscoe V.J., Clark N., et al. Diabetes in older adults: A consensus report. JAm Geriatr Soc 2012, 60:2342-2356.
78. Sinclair A., Morley J.E., Rodriguez-Mañas L., et al. Diabetes mellitus in older people: Position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes. JAm Med Dir Assoc 2012, 13:497-502.
79. Sinclair A.J., Paolisso G., Castro M., et al. European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary. Diabetes Metab 2011, 37:S27-38.
80. Morley J.E. Frailty: Diagnosis and management. JNutr Health Aging 2011, 15:667-670.
81. Abellan van Kan G., Rolland Y.M., Morley J.E., Vellas B. Frailty: Toward a clinical definition. JAm Med Dir Assoc 2008, 9:71-72.
82. Morley J.E., Vellas B., van Kan G.A., et al. Frailty consensus: A call to action. JAm Med Dir Assoc 2013, 14:392-397.
83. Gobbens R.J., van Assen M.A., Luijkx K.G., et al. Determinants of frailty. JAm Med Dir Assoc 2010, 11:356-364.
84. Malmstrom T.K., Morley J.E. Frailty and cognition: Linking two common syndromes in older persons. JNutr Health Aging 2013, 17:723-725.
85. Morley J.E. Clinical practice in nursing homes as a key for progress. JNutr Health Aging 2010, 14:586-593.
86. Mallery L.H., Ransom T., Steeves B., et al. Evidence-informed guidelines for treating frail older adults with type 2 diabetes: From the Diabetes Care Program of Nova Scotia (DCPNS) and the Palliative and Therapeutic Harmonization (PATH) program. JAm Med Dir Assoc 2013, 14:801-808.
87. Hager K.K., Loprinzi P., Stone D. Implementing diabetes care guidelines in long-term care. JAm Med Dir Assoc 2013, 14:851.e7-851.e15.
88. Boyle P.J., O'Neil K.W., Berry C.A., et al. Improving diabetes care and patient outcomes in skilled-care communities: Successes and lessons from a quality improvement initiative. JAm Med Dir Assoc 2013, 14:340-344.
89. Mooradian A.D., Perryman K., Fitten J., et al. Cortical function in elderly non-insulin dependent diabetic patients. Behavioral and electrophysiologic studies. Arch Intern Med 1988, 148:2369-2372.
90. Rolland Y., Tolson D., Morley J.E., Vellas B. The International Association of Gerontology and Geriatrics (IAGG) nursing home initiative. JAm Med Dir Assoc 2014, 15:307-308.
91. Rolland Y., De Souto Barreto P. Research can improve care in the nursing home. JAm Med Dir Assoc 2013, 14:233-235.
92. Tolson D., Rolland Y., Andrieu S., et al. The International Association of Gerontology and Geriatrics/World Health Organization/Society Française de Gérontologie et de Gériatrie Task Force. International Association of Gerontology and Geriatrics: A global agenda for clinical research and quality of care in nursing homes. JAm Med Dir Assoc 2011, 12:184-189.